Target intelligence / Profile preview

Inositol 1,4,5-trisphosphate receptor (IP3R)

Target
IP3R
Molecular classification
Ion channel, Ligand-gated ion channel, Endoplasmic reticulum membrane protein
01

Overview

Intracellular calcium release in hepatocytes is primarily mediated by the inositol 1,4,5-trisphosphate receptor (IP3R), a ligand-gated ion channel located on the endoplasmic reticulum membrane. Upon activation by second messenger IP3 (generated via PLC activation after stimulation by extracellular ligands like ATP, vasopressin, glucagon, and epinephrine), IP3R releases Ca^2+ from the ER into the cytosol. This rise in cytoplasmic calcium regulates diverse functions in the liver, such as cellular metabolism, secretion, proliferation, and the response to injury. Increases in intracellular calcium can also be mediated by ryanodine receptors, but in hepatocytes, IP3Rs are dominant. Pharmacological and pathological modulation of this pathway is implicated in liver regeneration, carcinogenesis, and liver injury responses.

Other names
IP3 receptorInsP3 receptorITPRITPR1/2/3calcium release channel
02

Mechanism of action

Ligand (IP3)-gated channel opening to release calcium from the endoplasmic reticulum (ER); Modulation by signaling pathways (PLC, G-protein coupled receptors/agonists such as ATP, vasopressin, glucagon, epinephrine)

03

Biological functions

Intracellular calcium releaseSignal transductionRegulation of gene transcriptionBile secretion modulation (in hepatocytes)Cell proliferation
04

Disease associations

Liver injury/regenerationCancerCell death/apoptosisMetabolic disordersOxidative stress/Cellular injury
05

Safety considerations

Non-specific modulation of intracellular calcium can lead to widespread effects including toxicity, cell death, and impaired organ function
06

Interacting drugs

2-APB (IP3R inhibitor)

1 more in the full profile.

07

Biomarkers

IP3R expression or phosphorylation status (research use)Intracellular calcium imaging (functional biomarker)

Beyond the preview

Go deeper on Inositol 1,4,5-trisphosphate receptor (IP3R).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Inositol 1,4,5-trisphosphate receptor (IP3R).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call